Lin Zhu

发表

FAT10 is associated with the malignancy and drug resistance of non-small-cell lung cancer

Yan-bin Zhao, Xue-song Chen, L. Cai, 2016, OncoTargets and therapy.

FaT 10 is associated with the malignancy and drug resistance of non-small-cell lung cancer

Yan-bin Zhao, Xue-song Chen, L. Cai, 2016 .

MicroRNA‐198 inhibition of HGF/c‐MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non–small‐cell lung cancer

Ying Cui, Feng Xue, Lin Zhu, 2018, Journal of cellular biochemistry.

Serum neuron specific enolase levels correlate with patient prognosis for advanced lung cancer.

Feng Xue, Lin Zhu, Liyan Wang, 2015, International journal of clinical and experimental medicine.

RETRACTED ARTICLE: Reduced LINC00467 elevates microRNA-125a-3p to suppress cisplatin resistance in non-small cell lung cancer through inhibiting sirtuin 6 and inactivating the ERK1/2 signaling pathway

Feng Xue, Lin Zhu, Quan Wang, 2021, Cell Biology and Toxicology.

miR-155-5p and miR-760 mediate radiation therapy suppressed malignancy of non-small cell lung cancer cells.

Ying Cui, Feng Xue, Lin Zhu, 2019, BioFactors.

Reduced LINC00467 Elevates microRNA-125a-3p to Suppress Cisplatin Resistance in Non-Small Cell Lung Cancer Through Inhibiting Sirtuin 6 and Inactivating the ERK1/2 Signaling Pathway

Feng Xue, Lin Zhu, Mingkun Liang, 2020 .

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Feng Xue, Lin Zhu, Ma-fei Kang, 2022, Frontiers in Oncology.

Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation.

Qiuyue Shao, Lin Zhu, J. Qin, 2023, Chemico-biological interactions.

The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.

Lin Zhu, Wenjing Tian, Xu Han, 2021, Future oncology.